Risks of malignancies related to tofacitinib and biological drugs in rheumatoid arthritis: Systematic review, meta-analysis, and network meta-analysis-Reference-Cited by-同舟云学术

Risks of malignancies related to tofacitinib and biological drugs in rheumatoid arthritis: Systematic review, meta-analysis, and network meta-analysis

Published:2017-10 Issue:2 Volume:47 Page:149-156
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Maneiro José Ramón,Souto Alejandro,Gomez-Reino Juan J.

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference38 articles.

1. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview;Singh;Can Med Assoc J.,2009

2. Therapies for active rheumatoid arthritis after methotrexate failure;OʼDell;N Engl J Med,2013

3. Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis;Meyer;J Inflamm (Lond),2010

4. Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial;Burmester;Lancet,2013

5. Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis;Fleischmann;N Engl J Med,2012

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from the IORRA Patient Registry;Rheumatology and Therapy;2024-07-17

2. Consenso para la gestión de riesgo en la prescripción de terapias biológicas o de antirreumáticos sintéticos con blanco dirigido: Asociación Colombiana de Reumatología 2023;Revista Colombiana de Reumatología;2024-04

3. Hunting uncertainties: JAK inhibitors and cancer risk;International Journal of Rheumatic Diseases;2024-02

4. Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician;Nature Reviews Rheumatology;2024-01-12

5. Clinical Evaluation of Collagen-Induced Arthritis in Female Lewis Rats: A Comprehensive Analysis of Disease Progression and Severity;CELL J;2023